iPSC neuron cells, back-engineered from a patient’s blood, are being studied in vitro in a Petri dish to better understand CAMK2 mutations and to help find medications that might help for the disorder.
Research progress and support
January 22, 2024 — Amazing Erasmus MC, a newsletter from the Erasmus Medical Center in Rotterdam, Netherlands, describes CAMK2 gene therapy research by pediatrician Danielle Veenma and neuroscientist Geeske van Woerden, scientific partners of CAMK2 Therapeutics Network.
https://amazingerasmusmc.com/brain/hope-placed-on-gene-therapy-for-rare-camk2-syndrome/
Photo: Scientist Geeske van Woerden (left) and pediatrician Daniëlle Veenma are working on genetic therapy for the CAMK2 syndrome.
“I am Caoimhe, I have CAMK2”
Medical writer Heather Mason recently posted this short piece on her Coufetery Comms website — an introduction to CAMK2 parent board member Nev Ross and his daughter, Caoimhe, who has CAMK2. For Mason’s full interview with Nev, see the link below.
Wisconsin family raises funds for research
June 23, 2023 — Local TV station CBS 58 in Wisconsin carries news of CAMK2 family’s fundraiser .